Skip to main content

Articles

A new study further confirms racial disparities in the quality of communication between physicians and patients.
Read More ›

Women diagnosed with aggressive breast cancer are more apt to receive adjuvant chemotherapy, but at the expense of completing locoregional radiation therapy.
Read More ›

Public health recommendations regarding diet and lifestyle to prevent heart disease and diabetes may also decrease a man’s likelihood of dying of prostate cancer.
Read More ›

By combining a cancer drug with a medication for erectile dysfunction and including a third therapy for heart transplants, researchers were able to kill cancer cells and protect the heart from damage.
Read More ›

Hispanic breast cancer survivors who believed their English-language proficiency to be limited were less likely to rate their own health as good, very good, or excellent.
Read More ›

The risk for estrogen receptor–negative and progesterone receptor–negative breast cancer is reduced with breast-feeding, according to study results.
Read More ›

Results of the first case-control study of the patterns and timing of sunlight exposure and how each is related to basal cell carcinoma and squamous cell carcinoma have been published.
Read More ›

When taken by colorectal cancer patients whose tumors carry a mutation in a key gene, aspirin can extend life.
Read More ›

Synribo (omacetaxine mepesuccinate) was recently approved by the FDA to treat adults with chronic myelogenous leukemia (CML) whose cancer has progressed after treatment with at least 2 tyrosine kinase inhibitors (TKIs).
Read More ›

Predicting a woman’s long-term risk for developing postmenopausal breast cancer was accomplished through the use of blood hormone testing.
Read More ›

Page 189 of 289